Xuan Tian Selected Research

etoposide phosphate (Etopophos)

1/2015	Recent progress on C-4-modified podophyllotoxin analogs as potent antitumor agents.
1/2009	A review on hemisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: 2003-2007.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xuan Tian Research Topics

Disease

4	Ischemic Stroke 11/2022 - 01/2020
3	Thrombosis (Thrombus) 02/2020 - 12/2012
3	Inflammation (Inflammations) 01/2020 - 01/2018
3	Stroke (Strokes) 01/2020 - 01/2020
3	Neoplasms (Cancer) 01/2015 - 01/2009
2	Hypoxia (Hypoxemia) 04/2022 - 01/2020
2	Reperfusion Injury 04/2022 - 01/2022
2	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2020
2	Wounds and Injuries (Trauma) 02/2020 - 02/2020
2	Brain Injuries (Brain Injury) 02/2020 - 01/2020
1	Cerebral Small Vessel Diseases 11/2022
1	Atherosclerotic Plaque (Atheroma) 02/2022
1	Death (Near-Death Experience) 11/2021
1	Liver Diseases (Liver Disease) 11/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Vascular System Injuries 02/2020
1	Pathologic Constriction (Stenosis) 02/2020
1	Cerebral Infarction 02/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020
1	Brain Edema (Cerebral Edema) 01/2020
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020
1	Disease Progression 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Memory Disorders (Memory Loss) 01/2018
1	Lung Neoplasms (Lung Cancer) 07/2014
1	Thromboembolism 12/2013
1	Venous Thromboembolism 06/2013
1	Embolism (Embolus) 12/2012
1	Carcinoma (Carcinomatosis) 03/2010
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2008
1	Body Weight (Weight, Body) 05/2004

Drug/Important Bio-Agent (IBA)

2	Indicators and Reagents (Reagents)IBA 11/2022 - 01/2020
2	Heme Oxygenase-1IBA 04/2022 - 01/2022
2	Pharmaceutical PreparationsIBA 01/2020 - 11/2008
2	Teniposide (VM 26)FDA Link 01/2015 - 01/2009
2	etoposide phosphate (Etopophos)FDA Link 01/2015 - 01/2009
2	Etoposide (VP 16)FDA LinkGeneric 01/2015 - 01/2009
1	CholesterolIBA 02/2022
1	LipidsIBA 02/2022
1	Iron Regulatory Protein 2IBA 01/2022
1	dicarboxydine (DCD)IBA 11/2021
1	CateninsIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2020
1	CotinineIBA 01/2020
1	Toll-Like Receptor 4IBA 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	CytokinesIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	AlbuminsIBA 01/2020
1	apelin-13 peptideIBA 01/2020
1	Interleukin-33IBA 01/2020
1	HomocysteineIBA 01/2018
1	ProdrugsIBA 01/2015
1	Fluorouracil (Carac)FDA LinkGeneric 07/2014
1	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2013
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 12/2012
1	Cisplatin (Platino)FDA LinkGeneric 03/2010
1	Podophyllotoxin (Condylox)FDA LinkGeneric 01/2009
1	Antimitotic AgentsIBA 01/2009
1	Irinotecan (Camptosar)FDA LinkGeneric 11/2008
1	CamptothecinIBA 11/2008
1	toosendaninIBA 05/2004

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 06/2020 - 07/2014
2	Liver Transplantation 04/2022 - 11/2021
2	Radiotherapy 06/2020 - 01/2020
2	Therapeutics 02/2020 - 01/2020
1	Vascular Surgical Procedures 02/2020
1	Ligation 02/2020
1	Contraindications 02/2020
1	Stents 02/2020
1	Sutures (Suture) 02/2020
1	Blood Vessel Prosthesis 02/2020
1	Surgical Amputation (Amputations) 02/2020
1	Thrombolytic Therapy 12/2013
1	Vena Cava Filters (Inferior Vena Cava Filter) 06/2013
1	Early Ambulation 12/2012